A world-first antiviral treatment has been developed for human papillomaviruses (HPVs) which can lead to mouth cancer.

NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first HPV antivirals.

Among the more than 100 types of human papillomavirus (HPV), at least 14 are considered as 'high-risk' types which can cause (cervical) cancer. After ...

James Carter Cathcart, the voice behind iconic Pokémon characters, passed away. He was 71. Cathcart battled throat cancer. He ...

Head and neck cancers, encompassing growths in the throat, larynx, nose, and mouth, account for 4% of cancers worldwide. Key ...

Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

One of the ways to detect cancer early is by undergoing regular screenings. There are different types of tests that one can get done that can help understanding the risks and in early diagnosis. Here ...

Sarah Waters, 33, was diagnosed with cervical cancer in 2022 after a routine smear test and has since had a full hysterectomy ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical ...

Cancer Research UK has awarded £457,000 to support a pioneering study in Cambridge that could play a pivotal role in the ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...